The meeting primarily focused on discussions surrounding pharmaceutical pricing transparency, with several members expressing the need for improved regulations to ensure that patients have a clear understanding of their medication costs. David Cook stressed the importance of empowering patients through transparency and articulated the harmful impacts of hidden fees and poor pricing models on access to care. The committee explored innovative solutions and legislative measures such as House Bill 3459 to foster better practices in the healthcare landscape, emphasizing a collaborative approach among stakeholders to enhance patient outcomes. Additionally, the chair and contributors discussed pressing issues related to pharmacy benefits managers (PBMs) and their influence on pricing. The participants highlighted the necessity for transparency in PBM practices to prevent miscommunication that could affect patient care. Several members encouraged continued advocacy for clarity within the healthcare pricing structures as a means to optimize patient access and to combat the challenges posed by complex reimbursement mechanisms. The session concluded with a commitment to maintain open dialogues and explore effective solutions for addressing these complex issues.